American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.
about
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapyPrimary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapyVenous Thromboembolism in Cancer: An Update of Treatment and Prevention in the Era of Newer AnticoagulantsAspirin in the Treatment of Cancer: Reductions in Metastatic Spread and in Mortality: A Systematic Review and Meta-Analyses of Published StudiesVenous thromboembolism and lung cancer: a reviewAnticoagulants in cancerBiomolecular markers of cancer-associated thromboembolismThromboprophylaxis guidelines in cancer with a primary focus on ambulatory patients receiving chemotherapy: a review from the Southern Network on Adverse Reactions (SONAR)Venous thromboembolism in the cancer population: pathology, risk, and preventionAngiogenic inhibitors for older patients with advanced colorectal cancer: does the age hold the stage?Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysisVenous and arterial thrombotic risks with thalidomide: evidence and practical guidanceWhat is the Best Treatment for a Cancer Patient with Thrombosis?Risk of venous thromboembolic events associated with VEGFR-TKIs: a systematic review and meta-analysisReal-Time Label-Free Embolus Detection Using In Vivo Photoacoustic Flow CytometryVenous thromboembolism in malignant gliomasCancer-associated thrombosis.Saddle pulmonary embolism in a cancer patient with thrombocytopenia: a treatment dilemma.Venous thromboembolism in patients with essential thrombocythemia and polycythemia vera.Low-molecular-weight heparin versus placebo for the prevention of venous thromboembolism in metastatic breast cancer or stage III/IV lung cancer.Treating venous thromboembolism in patients with cancer.The therapeutic management of bleeding and thrombotic disorders complicating CNS malignancies.Understanding, recognizing, and managing toxicities of targeted anticancer therapies.Enoxaparin dose reduction for thrombocytopenia in patients with cancer: a quality assessment study.Analysis of anticoagulation strategies for venous thromboembolism during severe thrombocytopenia in patients with hematologic malignancies: a retrospective cohort.Primary thromboprophylaxis in the palliative care setting: a qualitative systematic review.Venous thromboembolism prophylaxis and treatment in cancer: a consensus statement of major guidelines panels and call to action.Risk stratification for venous thromboembolism in patients with testicular germ cell tumors.Designing and implementing effective venous thromboembolism prevention protocols: lessons from collaborative efforts.The role of thromboprophylaxis in cancer patients: emerging data.Deep Vein Thrombosis of the Upper Extremity.Pattern of frequent but nontargeted pharmacologic thromboprophylaxis for hospitalized patients with cancer at academic medical centers: a prospective, cross-sectional, multicenter study.The potential benefits of low-molecular-weight heparins in cancer patientsUse of dexamethasone in patients with high-grade glioma: a clinical practice guidelineEvidence-based guidance on venous thromboembolism in patients with solid tumoursThe role of platelets in tumour growth.Heparin based prophylaxis to prevent venous thromboembolic events and death in patients with cancer - a subgroup analysis of CERTIFY.Role of factor xa inhibitors in cancer-associated thrombosis: any new data?Diagnosis and management of people with venous thromboembolism and advanced cancer: how do doctors decide? A qualitative study.Clinical practice guidelines and consensus statements in oncology--an assessment of their methodological quality.
P2860
Q24203644-6515BD58-3D3C-4F57-8FA4-2606AB73986FQ24235587-1E515478-434B-4B98-947D-21977C72FF85Q26741697-F0A1F2C7-656B-4907-81B7-DAAD25F77555Q26751511-CB9C9AC6-5BA0-4B03-81CF-A3CCCAC4718DQ26784184-8244EAB3-62CF-4DE8-819B-61192FF92184Q26825228-5712864B-5915-4AAA-9108-9AA2FC3C1B56Q26865716-05CD4D36-54F0-434E-8DC9-6708B105117EQ26995284-4F1DEEF8-D3EC-4718-AF2D-48BE70192A9AQ26996508-458E9FAD-2225-4741-99A5-7C601E19B775Q27002538-D93243E7-713D-49A3-9A34-D5D1AF205DD1Q27005043-9E2D848E-F2F1-42E8-892F-DBA6A42B92D0Q27008491-1278EDB2-C17A-4E9B-AFB0-1601459C1A80Q27009514-FF6E1D58-43EB-408E-8C6D-C18C6A766A12Q27026453-49013889-E7FA-4AED-B39B-07DE8E8CED3CQ30381707-317DDF74-D89A-46A9-B414-7818F33ED94CQ30436810-6ADB1136-047E-4778-AF55-BDB972F7330CQ33389006-B396520B-C4A9-4EDF-80F9-24A96F2070B1Q33393653-16C079F9-32AB-4F81-B887-CD58FD6C361AQ33398180-5310D68D-6F2F-46E6-BEF7-BAAD929C8D00Q33399333-A61F03BB-DDAC-46E5-958B-8BCC31DA8BEFQ33400564-C8443E04-0FEB-45D9-B257-DB5138A39280Q33402515-F0F3F871-BDFC-44A8-AEFD-517536B2F581Q33408049-8A93A6E7-CD95-4AAC-8D48-689926E39998Q33439387-38E106AA-C3EA-42CF-9951-488F251F80FAQ33440816-AB05D073-8AE5-4343-867D-ABE0391DC7C9Q33548617-E7AAE316-5035-41F6-B483-0E2742AD499DQ33561213-2F6922EC-693D-4F07-ADDF-8165E3CF020BQ33590396-6F6DE320-E603-4A4F-AC12-20C14D3FA5C6Q33619196-92B861FB-05B1-49EF-8876-792F036EC161Q33625063-9901DEC9-5D84-4E6A-BAF7-11B6A62A95B1Q33635174-B5B4C954-66F5-4E69-BF67-A9F60E0900FFQ33691499-6948B3C7-7938-44B7-8262-4120BCF08C8FQ33698360-1CA11217-FAF5-4769-9865-A38006EE59DBQ33763941-703253BB-AE16-4E4A-BE9B-FA58159C12D5Q33763946-8264C5D9-A4EB-4683-9507-77BAE63AAFDFQ33803558-E69155EF-90BF-4541-825B-2EA69B149713Q33972130-569F012E-3759-4725-8F90-D311A10E63D5Q34052232-CA197FA9-478F-4AAF-B6A8-CE199F0CF5F9Q34346557-56DE1EB9-2C13-4336-88E1-0432887D01D3Q34362184-FCAD804C-A159-4A85-A421-3F9A1243DA53
P2860
American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
American Society of Clinical O ...... tment in patients with cancer.
@en
type
label
American Society of Clinical O ...... tment in patients with cancer.
@en
prefLabel
American Society of Clinical O ...... tment in patients with cancer.
@en
P2093
P50
P356
P1476
American Society of Clinical O ...... atment in patients with cancer
@en
P2093
Ajay Kakkar
American Society of Clinical Oncology
Charles W Francis
Christopher Flowers
Daniel Clarke-Pearson
David Mendelson
David Trent
Gary H Lyman
Gary Raskob
Howard Liebman
P304
P356
10.1200/JCO.2007.14.1283
P407
P577
2007-10-29T00:00:00Z